A team led by Christian Baumgartner of the Institute of Health Care Engineering at Graz University of Technology (TU Graz) ...

Next-generation technologies and diagnostic tests offer the promise of improved cancer care, but they also present challenges related to ensuring widespread access to these innovations. To ensure ...

Renovaro Inc. announces funding approval for LUMINA, a platform detecting minimal residual disease in lung cancer using multi-omics and AI. Renovaro Inc. announced that its subsidiary, RenovaroCube, ...

Researchers are using AI and Xenon gas imaging to make MRI scans faster, cheaper, and more accurate, improving lung disease ...

Public Health Relevance Statement: Idiopathic Pulmonary Fibrosis (IPF) is fatal lung disorder for which no U.S. FDA-approved drugs currently exist. This project will lead to the development of novel ...

Celebrating five years of strong partnership, HCPLive® and the American Lung Association (ALA) are highlighting their ongoing commitment to advancing respiratory patient care. This strategic alliance ...

This project is not being offered for the current term. Please check back next semester for updates. Cancer cells have altered metabolism and consume significantly more glucose than normal cells, a ...

This project is not being offered for the current term. Please check back next semester for updates. The research of our laboratory is focused on lung embryonic specification and especially lung ...

Project Leader: A. Brent Carter, M.D. Idiopathic pulmonary fibrosis (IPF) is increasing in prevalence, and the recently approved anti-fibrotic therapies have limited efficacy. Alveolar macrophages ...

The University of Kentucky Markey Cancer Center's Graham Warren, M.D., Ph.D., and international collaborators have led a ...